Table 2.
Family |
Background |
Common-garden infection |
EB challenge |
|||||
---|---|---|---|---|---|---|---|---|
Nr | Group | N 0 (cops) | n S CG | % S CG | Tank distr % | N 0 (lice) | n S EB | % S EB |
1 |
Resistant |
278 |
124 |
44.6 |
23 - 27 |
123 |
57 |
46.3 |
2 |
Resistant |
214 |
97 |
45.3 |
23 - 32 |
95 |
54 |
56.8 |
3 |
Hybr (SxR) |
270 |
117 |
43.3 |
21 - 33 |
115 |
73 |
63.5 |
4 |
Hybr (SxR) |
276 |
128 |
46.4 |
17 - 34 |
123 |
91 |
74.0 |
5 |
Hybr (SxR) |
91 |
41 |
45.1 |
15 - 32 |
41 |
16 |
39.0 |
6 |
Hybr (SxR) |
191 |
79 |
41.4 |
22 - 33 |
78 |
32 |
41.0 |
7 |
Hybr (RxS) |
181 |
81 |
44.8 |
20 - 31 |
81 |
24 |
29.6 |
8 |
Hybr (RxS) |
582 |
288 |
49.5 |
23 - 27 |
285 |
117 |
41.1 |
9 |
Hybr (RxS) |
384 |
192 |
50.0 |
19 - 30 |
190 |
133 |
70.0 |
10 |
Sensitive |
171 |
49 |
28.7 |
22 - 33 |
49 |
4 |
8.2 |
11 |
Unknown |
325 |
151 |
46.5 |
22 - 29 |
149 |
14 |
9.4 |
12 |
Unknown |
450 |
195 |
43.3 |
21 - 30 |
190 |
15 |
7.9 |
13 |
Unknown |
318 |
60 |
18.9 |
20 - 30 |
57 |
5 |
8.8 |
14 |
Unknown |
230 |
91 |
39.6 |
22 - 29 |
91 |
13 |
8.8 |
15 |
Unknown |
157 |
77 |
49.0 |
21 - 29 |
77 |
29 |
37.7 |
16 |
Unknown |
240 |
103 |
42.9 |
20 - 33 |
101 |
9 |
8.9 |
17 |
Unknown |
196 |
93 |
47.4 |
23 - 28 |
90 |
27 |
30.0 |
All | 4 554 | 1 966 | 43.2 | 21 - 30 | 1 935 | 713 | 36.8 |
Group = experimental group, defined by the strain(s) of the mother and the father, see Table 1. N0 (cops) and N0 (lice) = initial numbers of copepodids and lice. n S = number of survivors at termination of CG = common-garden infection, and EB = emamectin benzoate trial, respectively. Tank distr % = between-tank distribution of individuals from the family at termination time, given as the minimum - maximum values from the four tanks. % S = number of surviving individuals as fractions of the initial numbers, in CG and EB, as described above.